Nat Neurosci. 2004 Jun;7(6):587-8. Epub 2004 May 16.

Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.

Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L.

Source

Department of Neuroscience, Clinical and Applied Physiology Program, University of Turin Medical School, Corso Raffaello 30, 10125 Turin, Italy. fabrizio.benedetti@unito.it

Abstract

Placebo administration is known to affect the brain both in pain and in Parkinson disease. Here we show that placebo treatment caused reduced activity in single neurons in the subthalamic nucleus of placebo-responsive Parkinsonian patients. These changes in activity were tightly correlated with clinical improvement; no decrease in activity occurred when the clinical placebo response was absent.

PMID:: 15146189; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Apomorphine

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Parkinson's Disease - MedlinePlus Health Information

Molecular Biology Databases

APOMORPHINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. [Exp Neurol. 2004]
Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
Priori A, Foffani G, Pesenti A, Tamma F, Bianchi AM, Pellegrini M, Locatelli M, Moxon KA, Villani RM. Exp Neurol. 2004 Oct; 189(2):369-79.
Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients. [Exp Neurol. 2010]
Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients.
Lafreniere-Roula M, Darbin O, Hutchison WD, Wichmann T, Lozano AM, Dostrovsky JO. Exp Neurol. 2010 Oct; 225(2):455-8. Epub 2010 Jul 24.
Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. [Exp Neurol. 2008]
Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ, Jenkinson N, Wang S, Holland P, Brittain JS, Joint C, Stein JF, Aziz T. Exp Neurol. 2008 Sep; 213(1):108-13. Epub 2008 May 22.
Review [Electrophysiology of subthalamic nucleus in normal and Parkinson's disease]. [Acta Neurol Taiwan. 2006]
Review [Electrophysiology of subthalamic nucleus in normal and Parkinson's disease].
Tai CH, Kuo CC. Acta Neurol Taiwan. 2006 Sep; 15(3):206-16.
Review [Placebo effect in Parkinson's disease]. [No To Shinkei. 2007]
Review [Placebo effect in Parkinson's disease].
Miwa H. No To Shinkei. 2007 Feb; 59(2):139-46.

See reviews... See all...

Cited by 16 PubMed Central articles

Review The placebo effect: advances from different methodological approaches. [J Neurosci. 2011]
Review The placebo effect: advances from different methodological approaches.
Meissner K, Bingel U, Colloca L, Wager TD, Watson A, Flaten MA. J Neurosci. 2011 Nov 9; 31(45):16117-24.
Review How placebo responses are formed: a learning perspective. [Philos Trans R Soc Lond B Biol...]
Review How placebo responses are formed: a learning perspective.
Colloca L, Miller FG. Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27; 366(1572):1859-69.
How the number of learning trials affects placebo and nocebo responses. [Pain. 2010]
How the number of learning trials affects placebo and nocebo responses.
Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. Pain. 2010 Nov; 151(2):430-9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Placebo-responsive Parkinson patients show decreased activity in single neurons ...
Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.
Nat Neurosci. 2004 Jun ;7(6):587-8. Epub 2004 May 16 .

PubMed
Gender nonconformity, childhood rejection, and adult attachment: a study of gay ...
Gender nonconformity, childhood rejection, and adult attachment: a study of gay men.
Arch Sex Behav. 2004 Apr ;33(2):117-28.

PubMed
Prenatal androgenization affects gender-related behavior but not gender identity...
Prenatal androgenization affects gender-related behavior but not gender identity in 5-12-year-old girls with congenital adrenal hyperplasia.
Arch Sex Behav. 2004 Apr ;33(2):97-104.

PubMed
The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2...
The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.
RNA. 2004 Jun ;10(6):929-41.

PubMed
Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls sp...
Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls spindle organization and mitotic entry.
Mol Biol Cell. 2004 Aug ;15(8):3642-57. Epub 2004 May 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: